Publication Bias in Antipsychotic Trials

Researchers in Oregon looked for discrepancies between published and unpublished FDA-registered trials. They found that four of the 24 FDA-registered trials of second-generation antipsychotics identified were unpublished. The mean effect size of the published trials was approximately double that of the unpublished trials. Results appeared this week in PLoS Medicine.

Article →

Related articles:
Washington Post
Medscape
Sydney Morning Herald
Fox News
Psych Central
ABC News

Recent News

Recent Blogs

Daisy Anderson
One Gutsy Woman January 29, 2015
Jeremy Wallace, MD
On Becoming Critical January 29, 2015

Around The Web

Related Posts

Publication Bias in Antipsychotic Trials Comments RSS

Leave a Reply